|
AR110125A1
|
|
POLYMERIC COMPOUNDS THAT RELEASE HYDROGEN SULFIDE
|
|
CN108348457A
|
|
The therapeutical uses of sterile aqueous ophthalmic solution
|
|
MX2018004779A
|
|
Therapeutic use of a sterile aqueous ophthalmic solution.
|
|
MA39767B1
|
|
Ophthalmic aqueous solution and dry eye syndrome treatment method
|
|
WO2011160146A1
|
|
Pharmaceutical preparation containing dextran and sodium hyaluronate for the treatment of joint disorders
|
|
WO2010031096A1
|
|
Antimicrobially and antivirally acting composition
|
|
EP2165701A1
|
|
Antimicrobial and antiviral compound
|
|
BRPI0722061A2
|
|
Use of a thiol group-containing polymer and implant
|
